The Presence and Profile of Neurological Conditions and Associated Psychiatric Comorbidities in U.S. Resettled Refugees: A Retrospective Single Center Study.
A Parvez, S Percac-Lima, A Saadi
https://pubmed.ncbi.nlm.nih.gov/36251204Actively Recruiting
Led by Massachusetts General Hospital · Updated on 2026-03-11
50
Participants Needed
1
Research Sites
39 weeks
Total Duration
M
Massachusetts General Hospital
Lead Sponsor
N
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
Researchers are evaluating a cognitive rehabilitation program designed to help refugees and asylum seekers who have experienced traumatic brain injury (TBI) and suffer from cognitive challenges like problems with thinking, learning, concentration, and memory. This study aims to test if the program is practical to use and if participants find it helpful. The trial involves English and Spanish speakers and is conducted by Massachusetts General Hospital using a randomized design. Participants are randomly assigned to one of two groups. One group receives the adapted cognitive rehabilitation program immediately, which includes eight virtual sessions led by a trained bilingual paraprofessional. These sessions teach strategies for managing cognitive symptoms, such as relaxation, attention, memory exercises, and education about TBI and related symptoms like depression and anxiety. The second group serves as a waitlist control, completing assessments before receiving the program approximately 12 weeks later. Both groups complete questionnaires at baseline, 12 weeks, and 24 weeks. During the study, participants complete assessments to measure how acceptable, feasible, and satisfying the program is, along with questionnaires assessing cognitive symptoms and post-concussion effects. The program lasts about eight weeks, and follow-up questionnaires occur at 12 and 24 weeks after starting. Researchers monitor adherence and participant feedback throughout. The trial is open to adults aged 18 to 65 who meet specific criteria and will continue until December 2027.
CONDITIONS
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - 1 day
Participants complete baseline assessments including target outcomes, demographic and general health information.
1 visit (virtual)
Duration - Approximately 8 weeks
Participants complete 8 individual virtual sessions with a trained bilingual paraprofessional focused on cognitive rehabilitation to address cognitive symptoms related to traumatic brain injury.
Weekly virtual sessions for 8 weeks
Duration - Up to 24 weeks after baseline
Participants complete follow-up questionnaires to assess acceptability, feasibility, satisfaction, and potential effectiveness of the intervention at 12 weeks and 24 weeks after baseline.
2 virtual assessments at approximately 12 weeks and 24 weeks after baseline
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
A
Altaf Saadi, MD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
A Parvez, S Percac-Lima, A Saadi
https://pubmed.ncbi.nlm.nih.gov/36251204Sofia Sherman Rosa, Rodrigo Nadal, Altaf Saadi
https://pubmed.ncbi.nlm.nih.gov/39874279Altaf Saadi, Jasmin Williams, Ameerah Parvez...
https://pubmed.ncbi.nlm.nih.gov/37019660Altaf Saadi, Julia Asfour, Maria Vassimon De Assis...
https://pubmed.ncbi.nlm.nih.gov/38928599Nusrath Jahan, Margarita Velasco, Ana-Maria Vranceanu...
https://pubmed.ncbi.nlm.nih.gov/38831593